Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Sues ApexBio Technology, Alleging Patent Infringement

This story has been updated to address requests for comment from Illumina and ApexBio Technology

NEW YORK – Illumina has sued ApexBio Technology, a Houston-based molecular biology reagents supplier, alleging patent infringement.

In a complaint filed Wednesday in the US District Court for the Southern District of Texas, Illumina alleged that in 2019, ApexBio began selling a next-generation sequencing library preparation kit for Illumina's platform without authorization, infringing Illumina's US Patent No.10,184,122 titled "Transposon End Compositions and Methods for Modifying Nucleic Acids."

Illumina said that in January 2019, ApexBio ordered two Illumina library preparation products. "After purchasing and examining Illumina's … products, ApexBio began making its own product," according to the complaint.

Illumina demanded a jury trial and asked the court for a declaration that ApexBio willfully infringed Illumina's patent, an injunction against the firm, damages, costs, and attorneys fees, among other relief.

The San Diego-based sequencing technology firm was issued the '122 patent nine days before ApexBio allegedly ordered the Illumina library prep products.

Illumina declined to comment. ApexBio did not respond to request for comment. 

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.